BioCryst Reports ZENITH-1 Results With Oral BCX7353 Which Confirm Rapid Onset of Action, Sustained Activity and Robust Dose Response for Treatment of Acute HAE Attacks

February 23, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search